Vyriad

Vyriad engineers targeted virus platforms that bring durable in vivo gene therapies, genome editing, and oncolytic virotherapies to patients.

Latest funding

$25M Series B+ · January 2, 2026

Website: vyriad.com.

X: @VyriadMN · 42 followers.

LinkedIn: vyriad.

Category: Health and bio.

Sectors: Biotechnology.

Stage: Series B+.

Based in: Rochester, United States.

Last round: Jan 2, 2026 · 314 days ago.

On Recent Funding since: Nov 6, 2026.

Signals

X account@VyriadMN · created Dec 10, 2021 (4 years old) · 42 followers

Website registeredNov 2, 2015 (11 years old)

TIMELINE · MONEY RAISED

@VyriadMN·Raised $25M in 1 sourced round·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

January 2, 2026
Series B+ · $25M
HHarry H. Stine (lead)
Source: fundraisingfox.com
May 18, 2022
Series B+ · amount undisclosed
Source: fundraisingfox.com
December 10, 2021
X account created
November 2, 2015
Website created

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vyriad (get a free API key).